Novartis reported $10.67B in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Alcon AG ALC:SW USD 1.94B 82M
Amgen AMGN:US USD 3.91B 504M
Artemis Alpha ATS:LN GBP 833K 39K
AstraZeneca AZN:LN USD 9.74B 495M
Bayer BAYN:GR EUR 10.08B 2.57B
Biogen BIIB:US USD 1.19B 1.45B
Bristol Myers Squibb BMY:US USD 8.75B 552M
Eli Lilly And LLY:US USD 5.27B 12.8M
Fresenius FRE:GR EUR 9.57B 399M
Fresenius Medical Care FME:GR EUR 4.62B 208M
Galapagos GLPG:NA EUR 185.62M 38.28M
Genmab GEN:DC DKK 2.16B 241M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Hikma Pharmaceutical HIK:LN USD 964M 118M
Johnson & Johnson JNJ:US USD 17.97B 211M
Lonza Group LONN:SW CHF 2.34B 4M
Merck MRK:GR EUR 4.57B 181M
Merk MRK:US USD 10.97B 1.31B
Novartis NOVN:VX USD 10.67B 183M
Novartis NVS:US USD 10.67B 183M
Orion ORNBV:FH EUR 246.4M 44.7M
Pfizer PFE:US USD 13.23B 2.41B
Philips PHIA:NA EUR 5.84B 1.67B
Recordati REC:IM EUR 362.35M 11.63M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Roche Holding ROG:VX 20.75B 3.26B